Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cumali Efe

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2012
Comment to "Unusual evolution of ciprofloxacin-induced hepatitis revealing a possible link with IgG4-associated autoimmune hepatitis"Cumali Efe
Autoimmunity Reviews|July 31, 2012
Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?Cumali Efe
Scandinavian Journal of Gastroenterology|December 28, 2020
Tacrolimus as second-line therapy in acute severe autoimmune hepatitisCumali Efe
Journal of Hepatology|February 27, 2016
Further considerations in autoimmune hepatitisErsan Ozaslan, Cumali Efe
Clinical Journal of Gastroenterology|April 8, 2020
Acute seronegative autoimmune hepatitis in the post-partum periodCumali Efe, Ersin Batıbay
Hepatology Communications|September 24, 2021
Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus UseCumali Efe, Staffan Wahlin
Journal of Hepatology|December 14, 2020
Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitisStaffan Wahlin, Cumali Efe
Hepatology (Baltimore, Md.)|May 19, 2022
Letter to the editor: Medical therapy of autoimmune hepatitis in pregnancyCumali Efe, Tuğrul Purnak
Hepatology Forum|July 5, 2022
Coronavirus disease 2019 (COVID-19) in autoimmune hepatitisSeyda Nur Dagli, Cumali Efe
Digestive Diseases and Sciences|June 19, 2015
Reply: To PMID 25002309Cumali Efe, Dimitrios P Bogdanos
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2012
Comment to "Unusual evolution of ciprofloxacin-induced hepatitis revealing a possible link with IgG4-associated autoimmune hepatitis"Cumali Efe
Autoimmunity Reviews|July 31, 2012
Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?Cumali Efe
Scandinavian Journal of Gastroenterology|December 28, 2020
Tacrolimus as second-line therapy in acute severe autoimmune hepatitisCumali Efe
Journal of Hepatology|February 27, 2016
Further considerations in autoimmune hepatitisErsan Ozaslan, Cumali Efe
Clinical Journal of Gastroenterology|April 8, 2020
Acute seronegative autoimmune hepatitis in the post-partum periodCumali Efe, Ersin Batıbay
Hepatology Communications|September 24, 2021
Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus UseCumali Efe, Staffan Wahlin
Journal of Hepatology|December 14, 2020
Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitisStaffan Wahlin, Cumali Efe
Hepatology (Baltimore, Md.)|May 19, 2022
Letter to the editor: Medical therapy of autoimmune hepatitis in pregnancyCumali Efe, Tuğrul Purnak
Hepatology Forum|July 5, 2022
Coronavirus disease 2019 (COVID-19) in autoimmune hepatitisSeyda Nur Dagli, Cumali Efe
Digestive Diseases and Sciences|June 19, 2015
Reply: To PMID 25002309Cumali Efe, Dimitrios P Bogdanos
Pageof 14